Programmed cell death in alcohol-associated liver disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD.
Abstract
Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD.
참고문헌 (46)
- Fuster D, "Alcohol use in patients with chronic liver disease", N Engl J Med, 379, pp.1251~1261 (2018)
- Seitz HK, "Alcoholic liver disease", Nat Rev Dis Primers, 4, pp.16~ (2018)
- Szabo G, "Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study", Hepatology, 69, pp.2271~2283 (2019)
- Gao B, "Inflammatory pathways in alcoholic steatohepatitis", J Hepatol, 70, pp.249~259 (2019)
- Nagy LE, "Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes", Gastroenterology, 150, pp.1756~1768 (2016)
- Kerr JF, "Apoptosis : a basic biological phenomenon with wide-ranging implications in tissue kinetics", Br J Cancer, 26, pp.239~257 (1972)
- Elmore S, "Apoptosis : a review of programmed cell death", Toxicol Pathol, 35, pp.495~516 (2007)
- Martinvalet D, "Granzyme A induces caspaseindependent mitochondrial damage, a required first step for apoptosis", Immunity, 22, pp.355~370 (2005)
- Malhi H, "Hepatocyte death : a clear and present danger", Physiol Rev, 90, pp.1165~1194 (2010)
- Luedde T, "Cell death and cell death responses in liver disease : mechanisms and clinical relevance", Gastroenterology, 147, pp.765~783.e4 (2014)
- Degterev A, "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury", Nat Chem Biol, 1, pp.112~119 (2005)
- Schwabe RF, "Apoptosis and necroptosis in the liver : a matter of life and death", Nat Rev Gastroenterol Hepatol, 15, pp.738~752 (2018)
- Yoon S, "MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation", Immunity, 47, pp.51~65.e7 (2017)
- Murphy JM, "The killer pseudokinase mixed lineage kinase domain-like protein(MLKL)", Cold Spring Harb Perspect Biol, 12, pp.a036376~ (2020)
- Wu X, "MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcoholic fatty liver disease", J Hepatol, 73, pp.616~627 (2020)
- Weinlich R, "Necroptosis in development, inflammation and disease", Nat Rev Mol Cell Biol, 18, pp.127~136 (2017)
- Roychowdhury S, "Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4-induced fibrosis but not steatosis or inflammation", Alcohol Clin Exp Res, 36, pp.1139~1147 (2012)
- Hao F, "Inhibition of caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice", Cell Death Dis, 8, pp.e3152~ (2017)
- Roychowdhury S, "Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury", Hepatology, 57, pp.1773~1783 (2013)
- Wang S, "Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcoholinduced steatosis and liver injury", Oncotarget, 7, pp.17681~17698 (2016)
- Fuchs Y, "Live to die another way : modes of programmed cell death and the signals emanating from dying cells", Nat Rev Mol Cell Biol, 16, pp.329~344 (2015)
- Ding WX, "Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice", Gastroenterology, 139, pp.1740~1752 (2010)
- Ueno T, "Autophagy in the liver : functions in health and disease", Nat Rev Gastroenterol Hepatol, 14, pp.170~184 (2017)
- Hazari Y, "Autophagy in hepatic adaptation to stress", J Hepatol, 72, pp.183~196 (2020)
- Thomes PG, "Acute and chronic ethanol administration differentially modulate hepatic autophagy and transcription factor EB", Alcohol Clin Exp Res, 39, pp.2354~2363 (2015)
- Kharbanda KK, "Flow cytometric analysis of vesicular pH in rat hepatocytes after ethanol administration", Hepatology, 26, pp.929~934 (1997)
- Kharbanda KK, "Ethanol consumption alters trafficking of lysosomal enzymes and affects the processing of procathepsin L in rat liver", Biochim Biophys Acta, 1291, pp.45~52 (1996)
- Chao X, "Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice", Gastroenterology, 155, pp.865~879.e12 (2018)
- Denaës T, "The cannabinoid receptor 2 protects against alcoholic liver disease via a macrophage autophagy-dependent pathway", Sci Rep, 6, pp.28806~ (2016)
- Cookson BT, "Pro-inflammatory programmed cell death", Trends Microbiol, 9, pp.113~114 (2001)
- Shi J, "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death", Nature, 526, pp.660~665 (2015)
- Kayagaki N, "Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling", Nature, 526, pp.666~671 (2015)
- Nagata S, "Programmed cell death and the immune system", Nat Rev Immunol, 17, pp.333~340 (2017)
- Lebeaupin C, "ER stress induces NLRP3 inflammasome activation and hepatocyte death", Cell Death Dis, 6, pp.e1879~ (2015)
- Petrasek J, "Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease", J Leukoc Biol, 98, pp.249~256 (2015)
- Heo MJ, "Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression", Gut, 68, pp.708~720 (2019)
- Dixon SJ, "Ferroptosis : an iron-dependent form of nonapoptotic cell death", Cell, 149, pp.1060~1072 (2012)
- Xie Y, "Ferroptosis : process and function", Cell Death Differ, 23, pp.369~379 (2016)
- Tsurusaki S, "Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis", Cell Death Dis, 10, pp.449~ (2019)
- Zhou Z, "Intestinal SIRT1 deficiency protects mice from ethanol-induced liver injury by mitigating ferroptosis", Am J Pathol, 190, pp.82~92 (2020)
- Li W, "Entry of hepatitis B and hepatitis D virus into hepatocytes : basic insights and clinical implications", J Hepatol, 64(1Suppl), pp.S32~S40 (2016)
- Wang H, "Characterization of ferroptosis in murine models of hemochromatosis", Hepatology, 66, pp.449~465 (2017)
- Silva I, "Does hypoxia cause carcinogenic iron accumulation in Alcoholic Liver Disease (ALD)?", Cancers (Basel), 9, pp.145~ (2017)
- Mueller S, "The role of iron in alcohol-mediated hepatocarcinogenesis", Adv Exp Med Biol, 815, pp.89~112 (2015)
- Nemeth E, "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization", Science, 306, pp.2090~2093 (2004)
- Zhou Z, "Adipose-specific Lipin-1 overexpression renders hepatic ferroptosis and exacerbates alcoholic steatohepatitis in mice", Hepatol Commun, 3, pp.656~669 (2019)
